Bone Density After Teriparatide Discontinuation in Premenopausal Idiopathic Osteoporosis

CONTEXT: Without antiresorptive therapy, postmenopausal women lose bone mass after teriparatide (TPTD) discontinuation; estrogen treatment prevents bone loss in this setting. It is not known whether premenopausal women with regular menses lose bone mass after teriparatide discontinuation. OBJECTIVE:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Cohen, Adi, Kamanda-Kosseh, Mafo, Recker, Robert. R., Lappe, Joan M., Dempster, David W., Zhou, Hua, Cremers, Serge, Bucovsky, Mariana, Stubby, Julie, Shane, Elizabeth
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702457/
https://ncbi.nlm.nih.gov/pubmed/26358172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-2829
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados